Viswanadhan Krishnan 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Agios (AGIO) Chief Corp Dev Krishnan Sells Shares After RSU Vesting
What Happened
Viswanadhan Krishnan, Chief of Corporate Development & Strategy at Agios Pharmaceuticals (AGIO), had 8,100 restricted stock units (RSUs) convert to common shares on March 5, 2026, and sold 2,959 of those shares in an open-market transaction at $27.80 per share, generating $82,260. The conversion/exercise of the RSUs is reported at $0.00 per share (typical for RSU settlements). The sale was to cover tax withholding related to the RSU vesting.
Key Details
- Transaction date: March 5, 2026. Filing date: March 9, 2026 (filed within the two-business-day window — timely).
- Conversion/exercise: 8,100 RSUs converted to 8,100 shares, recorded at $0.00.
- Open-market sale: 2,959 shares sold at $27.80, proceeds $82,260.
- Footnotes: Sale executed pursuant to durable automatic sale instructions included in the RSU agreement (consistent with a Rule 10b5-1 plan) to cover tax withholding. Each RSU equals one contingent share; the RSUs were granted March 5, 2025 and vest in three equal annual installments beginning March 5, 2026.
- Shares owned after the transaction: not specified in the provided filing summary.
Context
This was a conversion of RSUs with a partial sale to satisfy tax withholding — a routine administrative transaction rather than an outright unsolicited market sale. For RSU-related transactions, the exercise/conversion is often recorded at $0.00 because the units convert to shares without an out‑of‑pocket purchase; the subsequent sale to cover taxes is common and does not necessarily indicate a view on the company’s prospects.
Insider Transaction Report
- Exercise/Conversion
Common stock
2026-03-05+8,100→ 8,100 total - Sale
Common stock
[F1]2026-03-05$27.80/sh−2,959$82,260→ 5,141 total - Exercise/Conversion
Restricted stock units
[F2][F3]2026-03-05−8,100→ 16,200 total→ Common stock (8,100 underlying)
Footnotes (3)
- [F1]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 5, 2025.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.